Voltar
Revisão Acesso aberto Revisado por pares
BIBTEX RIS

Alzheimer's disease drug development pipeline: 2023

2023; Elsevier BV; Volume: 9; Issue: 2 Linguagem: Inglês

10.1002/trc2.12385

ISSN

2352-8737

Autores

Jeffrey L. Cummings, Yadi Zhou, Garam Lee, Kate Zhong, Jorge Ramón Fonseca Cacho, Feixiong Cheng,

Tópico(s)

Intensive Care Unit Cognitive Disorders

Resumo

Drugs that prevent the onset, slow progression, or improve cognitive and behavioral symptoms of Alzheimer's disease (AD) are needed.

Referência(s)